NCT06533098 A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Status RECRUITING Phase PHASE3
NCT06527690 Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT06516978 A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06500247 Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. Status NOT_YET_RECRUITING Phase PHASE2
NCT06498089 A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis Status RECRUITING Phase PHASE4
NCT06474481 Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06474273 TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients Status RECRUITING Phase PHASE3
NCT06470243 Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body Status RECRUITING Phase PHASE3
NCT06468943 Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06452537 Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06441097 Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06425302 A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06392841 Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations Status WITHDRAWN Phase PHASE2
NCT06387121 Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL Status RECRUITING Phase PHASE2
NCT06384222 Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone Status RECRUITING Phase PHASE2
NCT06378866 Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial Status RECRUITING Phase PHASE2
NCT06364319 Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD Status NOT_YET_RECRUITING Phase PHASE4
NCT06356129 Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE3